30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Arcus Biosciences Inc (RCUS)

Track

Over the last 90 days, Arcus Biosciences Inc. has seen significant insider selling activity, with total sales exceeding $6.7 million. Notably, officers Juan Jaen and Jennifer Jarrett have been involved in multiple large proposed and planned sales. There have been no reported insider purchases during this period. The stock has experienced a notable price increase of 32.9% over the same timeframe.
Stock chart
Ticker: RCUS Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Juan Jaen
Officer
1 sale — total 100,000 USD
Proposed sale 24 Jun 2026
Value US$3,705,449.38 | Price 71.24 | Shares 71,833
Planned sale 24 Jun 2026
Value US$1,694,584.62 | Price 249.40 | Shares 37,687
Planned sale 23 Jun 2026
Value US$100,000.00 | Price 28.06 | Shares 1,000
Planned sale 23 Jun 2026
Value US$100,000.00 | Price 27.69 | Shares 1,000
Planned sale 22 Jun 2026
Value US$100,000.00 | Price 27.03 | Shares 1,000
Proposed sale 22 Jun 2026
Value US$100,000.00 | Price 27.23 | Shares 1,000
Proposed sale 22 Jun 2026
Value US$100,000.00 | Price 27.23 | Shares 1,000
Planned sale 1 Jun 2026
Value US$66,023.76 | Price 25.77 | Shares 2,562
Proposed sale 1 Jun 2026
Value US$64,921.08 | Price 25.34 | Shares 2,562
Planned sale 11 May 2026
Value US$198,965.69 | Price 25.63 | Shares 7,763
Proposed sale 11 May 2026
Value US$198,965.69 | Price 25.63 | Shares 7,763
Proposed sale 6 May 2026
Value US$1,914,032.15 | Price 24.60 | Shares 77,793
Proposed sale 23 Apr 2026
Value US$1,356,562.11 | Price 25.20 | Shares 53,826
Proposed sale 8 Apr 2026
Value US$1,579,592.00 | Price 22.57 | Shares 70,000
Planned sale 5 Jan 2026
Value US$2,320.00 | Price 23.20 | Shares 100
Planned sale 5 Jan 2026
Value US$45,864.02 | Price 22.34 | Shares 2,053
Planned sale 5 Jan 2026
Value US$633,157.80 | Price 21.34 | Shares 29,670
Proposed sale 5 Jan 2026
Value US$692,786.71 | Price 21.77 | Shares 31,823
Planned sale 31 Dec 2025
Value US$153,185.76 | Price 23.38 | Shares 6,552
Proposed sale 18 Dec 2025
Value US$96,762.04 | Price 22.28 | Shares 4,343
Planned sale 18 Dec 2025
Value US$96,613.51 | Price 22.25 | Shares 4,343
Sale 17 Dec 2025
Value US$46,823.02 | Price 22.16 | Shares 2,113
Planned sale 17 Dec 2025
Value US$570,474.17 | Price 22.16 | Shares 25,744
Sale 17 Dec 2025
Value US$221,218.29 | Price 22.16 | Shares 9,983
Sale 17 Dec 2025
Value US$99,584.79 | Price 22.16 | Shares 4,494
Sale 17 Dec 2025
Value US$132,070.62 | Price 22.16 | Shares 5,960
Sale 17 Dec 2025
Value US$150,906.20 | Price 22.16 | Shares 6,810
Sale 17 Dec 2025
Value US$221,218.29 | Price 22.16 | Shares 9,983
Sale 16 Dec 2025
Value US$51,997.10 | Price 21.88 | Shares 2,376
Planned sale 16 Dec 2025
Value US$633,484.83 | Price 21.88 | Shares 28,947
Sale 16 Dec 2025
Value US$245,651.27 | Price 21.88 | Shares 11,225
Sale 16 Dec 2025
Value US$110,559.48 | Price 21.88 | Shares 5,052
Sale 16 Dec 2025
Value US$146,668.58 | Price 21.88 | Shares 6,702
Planned sale 16 Dec 2025
Value US$167,589.97 | Price 21.88 | Shares 7,658
Sale 16 Dec 2025
Value US$245,651.27 | Price 21.88 | Shares 11,225
Proposed sale 16 Dec 2025
Value US$219,000.00 | Price 21.90 | Shares 10,000
Proposed sale 16 Dec 2025
Value US$328,500.00 | Price 21.90 | Shares 15,000
Proposed sale 16 Dec 2025
Value US$109,500.00 | Price 21.90 | Shares 5,000
Proposed sale 16 Dec 2025
Value US$481,800.00 | Price 21.90 | Shares 22,000
Proposed sale 16 Dec 2025
Value US$306,600.00 | Price 21.90 | Shares 14,000
Proposed sale 16 Dec 2025
Value US$481,800.00 | Price 21.90 | Shares 22,000
Proposed sale 16 Dec 2025
Value US$1,204,500.00 | Price 21.90 | Shares 55,000
Planned sale 4 Dec 2025
Value US$2,050,598.58 | Price 24.71 | Shares 82,997
Proposed sale 4 Dec 2025
Value US$2,096,504.22 | Price 25.26 | Shares 82,997
Planned sale 26 Nov 2025
Value US$49,400.00 | Price 26.00 | Shares 1,900
Proposed sale 26 Nov 2025
Value US$46,132.00 | Price 24.28 | Shares 1,900
Proposed sale 26 Nov 2025
Value US$125,000.00 | Price 25.00 | Shares 5,000
Planned sale 26 Nov 2025
Value US$125,000.00 | Price 25.00 | Shares 5,000
Planned sale 18 Nov 2025
Value US$99,737.50 | Price 19.75 | Shares 5,050
Planned sale 17 Nov 2025
Value US$162,307.07 | Price 20.71 | Shares 7,836
Planned sale 17 Nov 2025
Value US$750,719.72 | Price 20.23 | Shares 37,114
Proposed sale 17 Nov 2025
Value US$999,500.00 | Price 19.99 | Shares 50,000
Planned sale 7 Nov 2025
Value US$954,065.53 | Price 18.97 | Shares 50,291
Planned sale 30 Oct 2025
Value US$87,649.70 | Price 20.32 | Shares 4,314
Proposed sale 30 Oct 2025
Value US$23,682.87 | Price 20.19 | Shares 1,173
Planned sale 29 Oct 2025
Value US$17,635.28 | Price 22.04 | Shares 800
Planned sale 29 Oct 2025
Value US$632,166.78 | Price 21.53 | Shares 29,365
Planned sale 29 Oct 2025
Value US$976,832.14 | Price 20.49 | Shares 47,675
Planned sale 28 Oct 2025
Value US$383,944.16 | Price 20.19 | Shares 19,019
Planned sale 28 Oct 2025
Value US$100,000.00 | Price 20.00 | Shares 5,000
Proposed sale 28 Oct 2025
Value US$1,988,000.00 | Price 19.88 | Shares 100,000
Proposed sale 28 Oct 2025
Value US$100,000.00 | Price 20.00 | Shares 5,000
Proposed sale 28 Oct 2025
Value US$100,000.00 | Price 20.00 | Shares 5,000
Planned sale 8 Oct 2025
Value US$568,610.87 | Price 15.05 | Shares 37,792
Planned sale 6 Oct 2025
Value US$181,801.25 | Price 14.54 | Shares 12,500
Proposed sale 6 Oct 2025
Value US$1,342,783.00 | Price 13.35 | Shares 100,583
Planned sale 29 Sep 2025
Value US$36,803.00 | Price 13.00 | Shares 2,831
Proposed sale 29 Sep 2025
Value US$36,350.04 | Price 12.84 | Shares 2,831
Proposed sale 5 Sep 2025
Value US$18,253.24 | Price 11.56 | Shares 1,579
Planned sale 5 Sep 2025
Value US$18,758.05 | Price 11.88 | Shares 1,579
Buy 27 Feb 2025
Value US$201,200.00 | Price 10.06 | Shares 20,000
Buy 27 Feb 2025
Value US$201,465.00 | Price 10.18 | Shares 19,800
Buy 18 Feb 2025
Value US$14,999,996.00 | Price 11.00 | Shares 1,363,636
Planned sale 31 Dec 2024
Value US$53,910.00 | Price 15.00 | Shares 3,594
Planned sale 2 Dec 2024
Value US$3,079.32 | Price 15.32 | Shares 201
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-24 2026-06-24 PrS Proposed sale
3.8
Juan Jaen

Officer

Officer
71,833
71.24
US$3,705,449 		71,833 71.24 US$3,705,449
2026-06-24 2026-06-24 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
37,687 +48.0%
249.40
US$1,694,585 		37,687 +48.0% 249.40 US$1,694,585
2026-06-24 2026-06-23 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
18,219 -33.2%
105.62
US$3,399,190 		18,219 -33.2% 105.62 US$3,399,190
2026-06-24 2026-06-23 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
1,000 -1.5%
27.69
US$100,000 		1,000 -1.5% 27.69 US$100,000
2026-06-24 2026-06-22 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
1,000 -1.0%
27.03
US$100,000 		1,000 -1.0% 27.03 US$100,000
2026-06-22 2026-06-22 PrS Proposed sale
3.8
Juan Jaen

Officer

Officer
1,000
27.23
US$100,000 		1,000 27.23 US$100,000
2026-06-22 2026-06-22 PrS Proposed sale
3.8
Juan Jaen

Officer

Officer
1,000
27.23
US$100,000 		1,000 27.23 US$100,000
2026-06-01 2026-06-01 PlS Planned sale
1.9
Azoy Alexander

Chief Accounting Officer

Officer
2,562 -6.1%
25.77
US$66,024 		2,562 -6.1% 25.77 US$66,024
2026-06-01 2026-06-01 PrS Proposed sale
1.9
ALEXANDER AZOY

Officer

Officer
2,562
25.34
US$64,921 		2,562 25.34 US$64,921
2026-05-12 2026-05-11 PlS Planned sale
3.5
Goeltz II Robert C.

Chief Financial Officer

Officer
7,763 -8.4%
25.63
US$198,966 		7,763 -8.4% 25.63 US$198,966
2026-05-11 2026-05-11 PrS Proposed sale
3.5
Robert C. Goeltz II

Officer

Officer
7,763
25.63
US$198,966 		7,763 25.63 US$198,966
2026-05-06 2026-05-06 PrS Proposed sale
3.5
JENNIFER JARRETT

Officer

Officer
77,793
24.60
US$1,914,032 		77,793 24.60 US$1,914,032
2026-04-23 2026-04-23 PrS Proposed sale
3.5
JENNIFER JARRETT

Officer

Officer
53,826
25.20
US$1,356,562 		53,826 25.20 US$1,356,562
2026-04-08 2026-04-08 PrS Proposed sale
3.5
JENNIFER JARRETT

Officer

Officer
70,000
22.57
US$1,579,592 		70,000 22.57 US$1,579,592
2026-01-07 2026-01-05 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
100 -0.0%
23.20
US$2,320 		100 -0.0% 23.20 US$2,320
2026-01-07 2026-01-05 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
2,053 -0.2%
22.34
US$45,864 		2,053 -0.2% 22.34 US$45,864
2026-01-07 2026-01-05 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
29,670 -3.1%
21.34
US$633,158 		29,670 -3.1% 21.34 US$633,158
2026-01-05 2026-01-05 PrS Proposed sale
3.8
Juan Jaen

Officer

Officer
31,823
21.77
US$692,787 		31,823 21.77 US$692,787
2026-01-02 2025-12-31 PlS Planned sale
3.5
Goeltz II Robert C.

Chief Financial Officer

Officer
6,552 -8.8%
23.38
US$153,186 		6,552 -8.8% 23.38 US$153,186
2025-12-18 2025-12-18 PrS Proposed sale
1.9
ALEXANDER AZOY

Officer

Officer
4,343
22.28
US$96,762 		4,343 22.28 US$96,762
2025-12-18 2025-12-18 PlS Planned sale
1.9
Azoy Alexander

Chief Accounting Officer

Officer
4,343 -19.0%
22.25
US$96,614 		4,343 -19.0% 22.25 US$96,614
2025-12-18 2025-12-17 S Sale
1.9
Azoy Alexander

Chief Accounting Officer

Officer
2,113 -8.5%
22.16
US$46,823 		2,113 -8.5% 22.16 US$46,823
2025-12-18 2025-12-17 PlS Planned sale
3.7
ROSEN TERRY J

Chief Executive Officer

Executive Director
25,744 -1.2%
22.16
US$570,474 		25,744 -1.2% 22.16 US$570,474
2025-12-18 2025-12-17 S Sale
3.8
Jaen Juan C.

President

Officer
9,983 -2.8%
22.16
US$221,218 		9,983 -2.8% 22.16 US$221,218
2025-12-18 2025-12-17 S Sale
1.9
Markus Richard

Chief Medical Officer

Officer
4,494 -6.4%
22.16
US$99,585 		4,494 -6.4% 22.16 US$99,585
2025-12-18 2025-12-17 S Sale
3.5
Goeltz II Robert C.

Chief Financial Officer

Officer
5,960 -7.4%
22.16
US$132,071 		5,960 -7.4% 22.16 US$132,071
2025-12-18 2025-12-17 S Sale
3.1
Tang Carolyn C.

General Counsel

Officer
6,810 -5.2%
22.16
US$150,906 		6,810 -5.2% 22.16 US$150,906
2025-12-18 2025-12-17 S Sale
3.5
Jarrett Jennifer

Chief Operating Officer

Officer
9,983 -4.9%
22.16
US$221,218 		9,983 -4.9% 22.16 US$221,218
2025-12-18 2025-12-16 S Sale
1.9
Azoy Alexander

Chief Accounting Officer

Officer
2,376 -8.7%
21.88
US$51,997 		2,376 -8.7% 21.88 US$51,997
2025-12-18 2025-12-16 PlS Planned sale
3.7
ROSEN TERRY J

Chief Executive Officer

Executive Director
28,947 -1.3%
21.88
US$633,485 		28,947 -1.3% 21.88 US$633,485
2025-12-18 2025-12-16 S Sale
3.8
Jaen Juan C.

President

Officer
11,225 -3.1%
21.88
US$245,651 		11,225 -3.1% 21.88 US$245,651
2025-12-18 2025-12-16 S Sale
1.9
Markus Richard

Chief Medical Officer

Officer
5,052 -6.7%
21.88
US$110,559 		5,052 -6.7% 21.88 US$110,559
2025-12-18 2025-12-16 S Sale
3.5
Goeltz II Robert C.

Chief Financial Officer

Officer
6,702 -7.7%
21.88
US$146,669 		6,702 -7.7% 21.88 US$146,669
2025-12-18 2025-12-16 PlS Planned sale
3.1
Tang Carolyn C.

General Counsel

Officer
7,658 -5.5%
21.88
US$167,590 		7,658 -5.5% 21.88 US$167,590
2025-12-18 2025-12-16 S Sale
3.5
Jarrett Jennifer

Chief Operating Officer

Officer
11,225 -5.2%
21.88
US$245,651 		11,225 -5.2% 21.88 US$245,651
2025-12-15 2025-12-16 PrS Proposed sale
1.9
Richard Markus

Officer

Officer
10,000
21.90
US$219,000 		10,000 21.90 US$219,000
2025-12-15 2025-12-16 PrS Proposed sale
3.1
Carolyn Tang

Officer

Officer
15,000
21.90
US$328,500 		15,000 21.90 US$328,500
2025-12-15 2025-12-16 PrS Proposed sale
1.9
Alexander Azoy

Officer

Officer
5,000
21.90
US$109,500 		5,000 21.90 US$109,500
2025-12-15 2025-12-16 PrS Proposed sale
3.5
Jennifer Jarrett

Officer

Officer
22,000
21.90
US$481,800 		22,000 21.90 US$481,800
2025-12-15 2025-12-16 PrS Proposed sale
3.5
Robert C. Goeltz, II

Officer

Officer
14,000
21.90
US$306,600 		14,000 21.90 US$306,600
2025-12-15 2025-12-16 PrS Proposed sale
3.8
Juan Jaen

Officer

Officer
22,000
21.90
US$481,800 		22,000 21.90 US$481,800
2025-12-15 2025-12-16 PrS Proposed sale
3.7
Terry Rosen, Ph.D.

Officer; Director

Executive Director
55,000
21.90
US$1,204,500 		55,000 21.90 US$1,204,500
2025-12-05 2025-12-04 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
82,997 -8.0%
24.71
US$2,050,599 		82,997 -8.0% 24.71 US$2,050,599
2025-12-04 2025-12-04 PrS Proposed sale
3.8
Juan Jaen

Officer

Officer
82,997
25.26
US$2,096,504 		82,997 25.26 US$2,096,504
2025-12-01 2025-11-26 PlS Planned sale
1.9
Azoy Alexander

Chief Accounting Officer

Officer
1,900 -6.5%
26.00
US$49,400 		1,900 -6.5% 26.00 US$49,400
2025-11-26 2025-11-26 PrS Proposed sale
1.9
ALEXANDER AZOY

Officer

Officer
1,900
24.28
US$46,132 		1,900 24.28 US$46,132
2025-11-26 2025-11-26 PrS Proposed sale
3.5
Robert C. Goeltz II

Officer

Officer
5,000
25.00
US$125,000 		5,000 25.00 US$125,000
2025-11-26 2025-11-26 PlS Planned sale
3.5
Goeltz II Robert C.

Chief Financial Officer

Officer
5,000 -5.4%
25.00
US$125,000 		5,000 -5.4% 25.00 US$125,000
2025-11-19 2025-11-18 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
5,050 -0.5%
19.75
US$99,738 		5,050 -0.5% 19.75 US$99,738
2025-11-19 2025-11-17 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
7,836 -0.7%
20.71
US$162,307 		7,836 -0.7% 20.71 US$162,307
2025-11-19 2025-11-17 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
37,114 -3.4%
20.23
US$750,720 		37,114 -3.4% 20.23 US$750,720
2025-11-17 2025-11-17 PrS Proposed sale
3.8
Juan Jaen

Officer

Officer
50,000
19.99
US$999,500 		50,000 19.99 US$999,500
2025-11-12 2025-11-07 PlS Planned sale
3.5
Jarrett Jennifer

Chief Operating Officer

Officer
50,291 -19.0%
18.97
US$954,066 		50,291 -19.0% 18.97 US$954,066
2025-11-03 2025-10-30 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
4,314 -0.4%
20.32
US$87,650 		4,314 -0.4% 20.32 US$87,650
2025-10-30 2025-10-30 PrS Proposed sale
3.8
Juan Jaen

Officer

Officer
1,173
20.19
US$23,683 		1,173 20.19 US$23,683
2025-10-30 2025-10-29 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
800 -0.1%
22.04
US$17,635 		800 -0.1% 22.04 US$17,635
2025-10-30 2025-10-29 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
29,365 -2.6%
21.53
US$632,167 		29,365 -2.6% 21.53 US$632,167
2025-10-30 2025-10-29 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
47,675 -4.1%
20.49
US$976,832 		47,675 -4.1% 20.49 US$976,832
2025-10-30 2025-10-28 PlS Planned sale
3.8
Jaen Juan C.

President

Officer
19,019 -1.6%
20.19
US$383,944 		19,019 -1.6% 20.19 US$383,944
2025-10-29 2025-10-28 PlS Planned sale
3.5
Goeltz II Robert C.

Chief Financial Officer

Officer
5,000 -5.1%
20.00
US$100,000 		5,000 -5.1% 20.00 US$100,000
2025-10-28 2025-10-28 PrS Proposed sale
3.8
Juan Jaen

Officer

Officer
100,000
19.88
US$1,988,000 		100,000 19.88 US$1,988,000
2025-10-28 2025-10-28 PrS Proposed sale
3.5
Robert C. Goeltz II

Officer

Officer
5,000
20.00
US$100,000 		5,000 20.00 US$100,000
2025-10-28 2025-10-28 PrS Proposed sale
3.5
Robert C. Goeltz II

Officer

Officer
5,000
20.00
US$100,000 		5,000 20.00 US$100,000
2025-10-08 2025-10-08 PlS Planned sale
3.5
Jarrett Jennifer

Chief Operating Officer

Officer
37,792 -15.0%
15.05
US$568,611 		37,792 -15.0% 15.05 US$568,611
2025-10-08 2025-10-06 PlS Planned sale
3.5
Jarrett Jennifer

Chief Operating Officer

Officer
12,500 -5.5%
14.54
US$181,801 		12,500 -5.5% 14.54 US$181,801
2025-10-06 2025-10-06 PrS Proposed sale
3.5
Jennifer Jarrett

Officer

Officer
100,583
13.35
US$1,342,783 		100,583 13.35 US$1,342,783
2025-09-30 2025-09-29 PlS Planned sale
1.9
Azoy Alexander

Chief Accounting Officer

Officer
2,831 -9.4%
13.00
US$36,803 		2,831 -9.4% 13.00 US$36,803
2025-09-29 2025-09-29 PrS Proposed sale
1.9
ALEXANDER AZOY

Officer

Officer
2,831
12.84
US$36,350 		2,831 12.84 US$36,350
2025-09-05 2025-09-05 PrS Proposed sale
1.9
ALEXANDER AZOY

Officer

Officer
1,579
11.56
US$18,253 		1,579 11.56 US$18,253
2025-09-05 2025-09-05 PlS Planned sale
1.9
Azoy Alexander

Chief Accounting Officer

Officer
1,579 -5.0%
11.88
US$18,758 		1,579 -5.0% 11.88 US$18,758
2025-02-27 2025-02-27 B Purchase
0.7
KANEKO YASUNORI
Non-Executive Director
20,000 +238.1%
10.06
US$201,200 		20,000 +238.1% 10.06 US$201,200
2025-02-27 2025-02-27 B Purchase
3.7
ROSEN TERRY J

Chief Executive Officer

Executive Director
19,800 +0.8%
10.18
US$201,465 		19,800 +0.8% 10.18 US$201,465
2025-02-20 2025-02-18 B Purchase
1.3
GILEAD SCIENCES, INC.
Large shareholder
1,363,636 +4.5%
11.00
US$14,999,996 		1,363,636 +4.5% 11.00 US$14,999,996
2025-01-03 2024-12-31 PlS Planned sale
3.5
Goeltz II Robert C.

Chief Financial Officer

Officer
3,594 -5.6%
15.00
US$53,910 		3,594 -5.6% 15.00 US$53,910
2024-12-04 2024-12-02 PlS Planned sale
1.9
Azoy Alexander

Chief Accounting Officer

Officer
201 -1.0%
15.32
US$3,079 		201 -1.0% 15.32 US$3,079
Explore more

More insider trading research around Arcus Biosciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America